 ## Insider Transactions: Who's Buying and Who's Running While the market speculates on where indices will go, insiders are voting with their money. Fresh data for May 2026 — two illustrative cases. ### ADMA Biologics — Director Buys ADMA is opening a new plasma collection center in Maryville, Tennessee — expanding its infrastructure. And at this moment, the company's director enters the market with a purchase. When a top manager who knows everything about the business invests their own money, it's one of the strongest signals. They see growth that the market hasn't yet priced in. ### Sea Ltd — Execs Sell $152 Million Sea Ltd had an excellent Q1 2026 report — revenue grew by 47%. The stock soared. And immediately, COO Gang Ye sells 20,000 shares, CCO sells another 1,600. Over the quarter, insiders dumped shares worth $152 million. When top managers of a company with the best quarterly report of the year exit their positions — it's not a coincidence. It's a signal that the current price has already priced in all the optimism. ### What This Means The ADMA director's purchase is a bet on an undervalued asset with real business expansion. Sea Ltd's top executives' sales are a classic "sell on good news." The market may ride the euphoria from Sea's report for another couple of weeks, but those on the inside are already exiting. ASI Biont analyzes such transactions in seconds — analyze insider patterns and make data-driven decisions. Try it for free, get 1500 tokens to start. → https://asibiont.com/